If you would like to receive press releases and other company information, enter email address below.
subscribe
unsubscribe
(12/3/2007)
JENEX ANNOUNCES $2 MILLION PRIVATE PLACEMENT
(11/30/2007)
interceptCS Featured in Syndicated National Column
(11/8/2007)
THE JENEX CORPORATION ISSUES SHARES FOR DEBT
(10/30/2007)
Jenex Approved for Publication by Standard & Poor's
(10/25/2007)
Jenex Receives Regulatory Approval in Australia
(10/4/2007)
JENEX CLOSES 1,915,000 UNIT OFFERING
(10/2/2007)
Jenex signs Distribution Agreement for Australia and New Zealand.
(9/20/2007)
Jenex Featured at www.WallStreetCorner.com
(9/12/2007)
THE JENEX CORPORATION REVISES INCENTIVE STOCK OPTIONS
(8/2/2007)
Jenex Gains European Approval to Market
(6/15/2007)
Jenex Featured On MoneyTV Interview
(2/28/2007)
THE JENEX CORPORATION GRANTS WORLDWIDE LICENSE TO
(2/19/2007)
THE JENEX CORPORATION ISSUES PROGRESS REPORT
(9/14/2006)
PRIVATE PLACEMENT
(7/20/2006)
LAUNCHES THERAPIK in CHINA and EUROPE
(5/26/2006)
THERAPIK PROGRESS REPORT
(5/25/2006)
InterceptCS PROGRESS REPORT
(3/22/2006)
THE JENEX CORPORATION ISSUES PROGRESS REPORT
(3/16/2006)
JENEX CLOSES $190,000 PREVIOUSLY ANNOUNCED FINANCING
(2/10/2006)
JENEX CORPORATION FINANCING
(1/16/2006)
JENEX AND WARRANT HOLDER AGREE TO RESCIND 1,250,000 WARRENTS
(1/12/2006)
JENEX RAISES $1.02 MILLION IN THREE FINANCINGS
(12/22/2005)
PRIVATE PLACEMENT
(9/26/2005)
THE JENEX CORPORATION ISSUES PROGRESS REPORT FOR COLD SORE PREVENTION PRODUCT
(5/27/2005)
SHARES FOR DEBT
(5/26/2005)
JENEX AGREES TO U.S. MARKET TEST FOR THERAPIK
(5/19/2005)
THE JENEX CORPORATION
(4/14/2005)
Jenex to issue 250,000 shares for debt
(2/14/2005)
The Jenex Corporation Submits Response to SEC Filing
(2/4/2005)
Jenex grants 25-cent stock options
(12/19/2004)
THE JENEX CORPORATION (C - JEN) - Private Placement
(11/5/2004)
JENEX / SHOPPERS DRUG MART TO LAUNCH interceptCS
(7/14/2004)
Jenex Receives First Revenue From Licensing Agreement
(6/15/2004)
Jenex Signs Licensing Agreement for Therapik Product in Asia
(6/9/2004)
Jenex Reports On Progress Towards Canadian Launch
(5/17/2004)
Jenex Signs Strategic Partnership with Competitive Technologies, Inc.
(5/7/2004)
TSX APPROVES SHARES FOR DEBT
(5/5/2004)
THE JENEX CORPORATION ANNOUNCES LISTING ON FRANKFURT STOCK EXCHANGE
(4/29/2004)
Jenex Corporation and UTEK Corporation Announce Strategic Alliance for Healthcare and Consumer Products Technology Transfer
(4/23/2004)
THE JENEX CORPORATION TO EXPLORE TECHNOLOGY ACQUISITION OPPORTUNITIES
(4/13/2004)
THE JENEX CORPORATION ANNOUNCES LISTING ON BERLIN-BREMEN STOCK EXCHANGE
(3/31/2004)
The Jenex Corporation Announces Appointment of The Gibson Group as Advertising Agency of Record
(3/23/2004)
JENEX CLOSES $977,000 FINANCING
(3/15/2004)
Jenex Announces Private Placement
(2/25/2004)
Jenex Announces Private Placement
(7/16/2003)
Cold Sore Prevention Device in Final Stages of Design
(6/9/2003)
Mr. Wayne Izumi Appointed To Jenex Board Of Directors
(6/6/2003)
Contracted Completion Of Product Design
(5/8/2003)
AMENDED PRIVATE PLACEMENT
(2/13/2003)
PRIVATE PLACEMENT OF CONVERTIBLE DEBENTURE
(2/13/2003)
JENEX’S TECHNOLOGY MAY PROVE EFFECTIVE AGAINST WEST NILE VIRUS
(2/10/2003)
Jenex Grants Options
(8/27/2002)
Sherry Torkos, Health Care Professional Joins Advisory Committee
(7/11/2002)
Jenex Announces Private Placement
(7/10/2002)
Jenex Corporate Update
(6/28/2002)
Jenex Regulatory Update
(6/10/2002)
Herpes Virus Expert, Dr. Stephen Sacks Joins Jenex Advisory Committee
(5/27/2002)
Jenex Completes Acquisition of European and Australian Patents
(5/8/2002)
Debt Reduced Through Issuance Of Jenex Common Stock
(3/11/2002)
Private Placement
(3/7/2002)
Mr. Anthony Felice Joins Advisory Committee
(3/5/2002)
Mr. Jacques Tricoire Joins Advisory Committee
(2/18/2002)
FDA amendment submitted
(2/11/2002)
Mr. Greg Nordal Joins Advisory Committee
(1/28/2002)
Nominated for New Venture/New Product Award
(1/24/2002)
Advisory Committee Grows - Mr. Gilbert Smith Accepts Appointment
(1/23/2002)
Jenex announces medical breakthrough to prevent cold sores
(11/22/2001)
Notice of special and annual meeting of shareholders
(7/10/2001)
The Jenex Corporation Completes its Initial Public Offering
Copyright the Jenex Corporation 2001© |
Disclaimer
